
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 31, 2024, titled "Glenmark partners with Pfizer to launch Abrocitinib in India ".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 31, 2024, titled "Glenmark partners with Pfizer to launch Abrocitinib in India ".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals